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Amyloid ﬁbrils, such as those found in Alzheimer’s and
the gelsolin amyloid diseases, result from the misassembly
of peptides produced by either normal or aberrant intra-
cellular proteolytic processing. A paper in this issue by
Marks and colleagues (Berson et al., 2003) demonstrates
that intra-melanosome ﬁbrils are formed through normal
biological proteolytic processing of an integral membrane
protein. The resulting peptide fragment assembles into
 
ﬁbrils promoting the formation of melanin pigment granules.
These results, along with the observation that amyloid
ﬁbril formation by bacteria is highly orchestrated, suggest
 
that ﬁbril formation is an evolutionary conserved biological
pathway used to generate natural product nanostructures.
 
Protein folding disorders are now recognized to result in a
large number of human diseases including those involving
amyloid fibril deposition (Aridor and Balch, 1999; Kelly,
1996). Amyloid is generally considered to be a nonnative
quaternary structure that forms in response to a defect in the
normal folding or clearance pathways. Amyloid fibrils appear
 
in electron micrographs as 
 
 
 
100-Å diameter twisted rods
composed of a cross–
 
 
 
-sheet structure that selectively bind
the dye Congo red and the environment-dependent fluorphore
thioflavin T. Two publications now provide tantalizing
evidence that fibril formation (amyloidogenesis) may be an
evolutionary conserved mechanism for creating biologically
active quaternary structures. One paper, by Marks and
colleagues (Berson et al., 2003, this issue), examines the
mechanism of fibril formation in the melanosome, and a
second describes the formation of extracellular fibers on the
cell surface of 
 
E. coli
 
 and 
 
Salmonella
 
 that are involved in the
colonization of inert surfaces (Chapman et al., 2002).
Melanosomes are subcellular organelles that specialize in
the synthesis of pigment granules (melanin) in melanocytes
and retinal epithelial cells (Marks and Seabra, 2001; Raposo
and Marks, 2002). Melanin is a detergent-insoluble matrix
whose assembly is a consequence of a carefully orchestrated
metabolic pathway. Marks and colleagues (Berson et al.,
2003) have now extended our understanding of this path-
way. They found that mammalian melanocytes produce a
glycoprotein called Pmel17, a type I integral membrane pro-
tein, that polymerizes into amyloid-like fibrils, on which
melanins are sequestered and concentrated during the multi-
stage process of melanosome biogenesis. Remarkably, they
demonstrate that endoproteolysis is required for the intra-
lumenal assembly of Pmel17 into fibrils. The key protease is
 
the proprotein convertase furin, a Ca
 
2
 
 
 
-dependent membrane-
associated protein that recycles between the cell surface,
endocytic compartments, and the trans-Golgi network.
Furin cleaves Pmel17 during the maturation of stage I pre-
melanosomes to stage II–III melansomes to yield a 28-kD 
 
 
 
fragment associated with the membrane and an 80-kD 
 
 
 
cytosolic fragment (M
 
 
 
). Only the proteolytically processed
M
 
 
 
 fragment of Pmel17 is able to form fibrils that can be
recovered in a detergent-insoluble fraction, a characteristic
of most amyloid fibrils.
In bacteria, electron microscopy has shown that the Curli
protein (17.5 kD) forms a tangled fibrous matrix on the out-
side of the cell wall. Curli has all the hallmarks of typical
amyloid (Chapman et al., 2002). Formic acid treatment is
required to depolymerize the CsgA protein comprising
Curli. Curli CsgA fibers are SDS resistant and adopt a cross–
 
 
 
-sheet amyloid fibril structure as revealed by far-ultraviolet
circular dichoism spectroscopy, a red shifted Congo red
spectrum and a thioflavin T binding–induced fluorescence
identical to that exhibited by pathological amyloid fibrils.
Curli amyloidosis, like melanosome biogenesis, is highly
orchestrated by two 
 
E. coli
 
 operons, csgAB and csgDEFG.
The CsgB protein, likely in collaboration with CsgF, is
thought to nucleate CsgA fiber formation. The CsgG lipo-
protein localizes to the inner leaflet of the outer membrane,
possibly serving as the Curli assembly platform. CsgD is a
FixJ-like transcription factor on the same operon with CsgE,
-F, and -G, which may be assembly factors. Purification of
 
CsgA-His
 
6
 
 on a nickel column revealed a metastable fiber-free
 
solution of CsgA. Upon standing, this CsgA-His
 
6
 
 solution
formed fibrils indistinguishable from those characterizing
membrane-associated Curli. Thus, other genes in the operon
may be required to prevent intracellular amyloidosis, consistent
with the recent results of Lindquist and colleagues (Ma et
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al., 2002), demonstrating that intracelullar prion (amyloid)
formation in yeast may be very toxic.
Extracellular Curli formation by bacteria together with
the intralumenal formation of pMel17 M
 
 
 
 fibrous striations
by mammalian cells demonstrate that amyloid-like fibrils
can be a natural product—a quaternary protein nanostruc-
ture formed by biological systems. The fact that mammalian
cells utilize a fibril structure to mediate function emphasizes
that tuning of protein structure by proteolysis can be a very
powerful determinant for expanding the biological diversity
of polypeptides. It is apparent that 
 
E. coli
 
 and 
 
Salmonella
 
 go
to great lengths to control amyloidogenesis, as evidenced by
the dedication of at least two operons to harness the poten-
tial of the amyloid quaternary structure to perform a useful
biological function, and to prevent misassembly elsewhere in
the cell. It is almost certain that numerous mammalian genes
are also used to control amyloid-like fibril formation within
organelles such as the melanosome to allow to its potential
to be recognized. Interestingly, the process of normal mam-
malian fibril formation in the melanosome pathway demon-
strated in this issue (Berson et al., 2003) is similar to the reg-
ulated proteolytic processing of precursor proteins leading to
the formation of other lysosome-related organelles, includ-
ing lamellar bodies in lung epithelial cells and Weibel-Palade
bodies in endothelial cells. The proposal that biological con-
trol of fibril formation is stringently controlled is consistent
with the idea that transport from the ER to intracellular and
extracellular compartments is likely to require rigid control
of the assembly state of the protein (Aridor and Balch,
1999). These examples of biological fibrillogenesis from
three different organisms are likely only a prelude to the dis-
covery of other amyloid-like nanostructures that represent
intermediates or end products in metabolic folding path-
ways.
Pathways whereby fibril functions as a natural product are
strikingly reminiscent of the pathological process of amy-
loidogenesis, where a subset of “amyloidogenic” precursor
proteins are proteolytically processed into amyloidogenic
peptide fragments by one or more proteases (Kelly, 1996).
Human amyloid pathologies known to require proteolytic
processing of a precursor protein include Alzheimer’s disease
 
where the A-
 
 
 
 peptide is liberated from a large APP precur-
sor protein by 
 
 
 
- and 
 
 
 
-secretases, secondary systemic amy-
loidosis where the SAA protein is liberated by a minimum of
one proteolytic cleavage, and type II diabetes where the
aberrant proteolytic processing of pro-islet amyloid poly-
peptide leads to amyloid inclusions in the endoplasmic retic-
ulum. Most relevant to mammalian melanosome amyloido-
genesis is familial amyloidosis of Finnish type (Chen et al.,
2001) and familial British dementia (Kim et al., 2002). The
D187N and D187Y variants of gelsolin are aberrantly pro-
cessed by furin. Normally, wild-type gelsolin is stabilized by
Ca
 
2
 
 
 
 binding in the trans-Golgi resulting in the burial of the
furin consensus site. In the mutants, this stabilization does
not occur and furin is allowed access to a protein it does not
normally cleave. Furin cleavage liberates an amyloidogenic
fragment that then assembles into amyloid fibrils.
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